"Designed" grafts for HLA-haploidentical stem cell transplantation

Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation

(2013) D. Schneidawind et al.   BLOOD

Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device

(2013) Michael Schumm et al.   CYTOTHERAPY

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

(2013) Asad Bashey et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

(2012) Stefan O. Ciurea et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies

(2012) P. Di Bartolomeo et al.   BLOOD

Next-generation leukemia immunotherapy

(2011) K. Vincent et al.   BLOOD

Haploidentical hematopoietic transplantation: current status and future perspectives

(2011) Y. Reisner et al.   BLOOD

Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

(2011) C. Ustun et al.   BLOOD

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

(2011) A. Veerapathran et al.   BLOOD

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

(2011) M. Di Ianni et al.   BLOOD

Human FoxP3+ CD4+ regulatory T cells: their knowns and unknowns

(2011) Makoto Miyara et al.   IMMUNOLOGY AND CELL BIOLOGY

Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison

(2010) Yu Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention

(2010) A. Gaidot et al.   BLOOD

The role of V 2-negative    T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation

(2010) A. Knight et al.   BLOOD

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

(2010) T. Feuchtinger et al.   BLOOD

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

(2010) C. G. Brunstein et al.   BLOOD

A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease

(2010) I. Tawara et al.   JOURNAL OF IMMUNOLOGY

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

(2010) Anita Schmitt et al.   TRANSFUSION

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia

(2009) Q. Zhou et al.   BLOOD

Immunomagnetic isolation of CD4+CD25+FoxP3+natural T regulatory lymphocytes for clinical applications

(2009) M. Di Ianni et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: How NK cells make the difference

(2009) Franco Locatelli et al.   CLINICAL IMMUNOLOGY

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia

(2009) Andrea Velardi et al.   CURRENT OPINION IN IMMUNOLOGY

Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression

(2009) Ethan M. Shevach   IMMUNITY

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

(2009) Fabio Ciceri et al.   LANCET ONCOLOGY

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

(2008) F. Ciceri et al.   BLOOD

Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias

(2008) Alessandro Moretta et al.   IMMUNOLOGICAL REVIEWS

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

(2007) V. H. Nguyen et al.   BLOOD

T cell therapy of Epstein–Barr virus and adenovirus infections after hemopoietic stem cell transplant

(2007) P. Comoli et al.   BLOOD CELLS MOLECULES AND DISEASES

Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation

(2007) Katia Perruccio et al.   BLOOD CELLS MOLECULES AND DISEASES